The Glaucoma Treatment Market size is valued at US$ 7.2 Bn in 2026.
The Glaucoma Treatment Market is projected to grow at a CAGR of 5% by 2033.
The Glaucoma Treatment Market growth is driven by rising glaucoma prevalence, growing geriatric population, and increasing awareness regarding eye care.
North America is a dominating region for Glaucoma Treatment Market.
AbbVie Inc., Novartis AG, Pfizer Inc., Bausch + Lomb Corporation, and Glaukos Corporation are some leading industry players in the Glaucoma Treatment Market.